CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer
Jwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, Yong Jun Cha, Joong Bae Ahn, Han Sang Kim, Keun-Wook Lee, Ji-Won Kim, Tae-You Kim, Won Jin Chang, Joon Oh Park, Jihun Kim, Jeong Eun Kim, Yong Sang Hong, Yeul Hong Kim, Tae Won Kim
Cancer Research and Treatment. 2020;52(4):1135-1144.   Published online 2020 April 24    DOI:

Excel Download

Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability‐high/mismatch repair‐deficient or POLE ‐mutated metastatic or unresectable colorectal cancer
International Journal of Cancer. 2022;150(12):2038-2045   Crossref logo
Link1 Link2 Link3

Phase 2 study of tislelizumab monotherapy in previously treated, locally advanced, unresectable or metastatic microsatellite instability-high/mismatch repair-deficient solid tumors: Gynecological cancer subgroup (127)
Gynecologic Oncology. 2022;166:S80-S81   Crossref logo
Link1 Link2

The cost-effectiveness analysis of serplulimab versus regorafenib for treating previously treated unresectable or metastatic microsatellite instability-high or deficient mismatch repair colorectal cancer in China
Frontiers in Oncology. 2023;13:   Crossref logo

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer
ESMO Open. 2021;6(3):100145   Crossref logo
Link1 Link2

EE416 Cost-Effectiveness of Pembrolizumab Monotherapy for First-Line Treatment in Adult Patients with Microsatellite Instability High/Mismatch Repair-Deficient Metastatic Colorectal Cancer From a French Perspective
Value in Health. 2022;25(12):S137   Crossref logo
Link1 Link2

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as the first-line treatment in patients with mismatch-repair-deficient (dMMR) or microsatellite- instability-high (MSI-H) advanced or metastatic colorectal cancer from a perspective of health care system in China
. 2023;   Crossref logo
Link1 Link2

Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer
European Journal of Cancer. 2021;144:9-16   Crossref logo
Link1 Link2

Are High Levels of Microsatellite Instability and Microsatellite Stability Identical in DNA Mismatch Repair-Deficient Colorectal Cancer Patients?
Canadian Journal of Gastroenterology and Hepatology. 2023;2023:1-6   Crossref logo
Link1 Link2 Link3

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
Journal for ImmunoTherapy of Cancer. 2020;8(2):e001499   Crossref logo

Microsatellite Instability and Mismatch Repair Genes in Colorectal Cancer: Useful Tools for Managing Patients and Counseling Their Relatives
Clinical Colorectal Cancer. 2010;9(4):193-194   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.